Article
One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing…
Clinical Ophthalmology · 2025 · Rush RB, Klein W, Rush SW, Reinauer R
Key facts
| Title | One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy |
|---|---|
| First author | Rush RB, Klein W, Rush SW, Reinauer R |
| Journal | Clinical Ophthalmology |
| Published | Jan 9, 2025 |
| DOI | 10.2147/OPTH.S498985 |
| Devices mentioned | K101223, K113129, K121993, K152205, K172649, K173648, K181594, K182569, K192391, K201252, K223557, K240221 and 1 more |
| Product codes mentioned | HOO, OBO, MYC, MXK, HPT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1